human prostate cancer lncap cells (ATCC)
Structured Review
Human Prostate Cancer Lncap Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 2665 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+prostate+cancer+lncap/LNCaP+clone+FGC/pm42020612-50-0-5
Average 99 stars, based on 2665 article reviews
Images
Related Articles
Transformation Assay:Article Title: Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer Article Snippet: .. Biomarker Discovery:Article Title: Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors Article Snippet: AntihCD44 FITC was from MACS, Miltenyi Biotec, Cat#130-113-903; alkaline phosphatase-labeled anti-DIG IgG was from Roche, Cat # 11585762001). .. Validation Antibodies were validated with purified antigens if available, and with cell lysate by immunobtotting ary O ctober 2018 Eukaryotic cell lines Policy information about cell lines Cell line source(s) Human embryonic kidney HEK293 (Cat# CRL-1573), human prostate cancer PC-3 (Cat# CRL-1435), Purification:Article Title: Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors Article Snippet: AntihCD44 FITC was from MACS, Miltenyi Biotec, Cat#130-113-903; alkaline phosphatase-labeled anti-DIG IgG was from Roche, Cat # 11585762001). .. Validation Antibodies were validated with purified antigens if available, and with cell lysate by immunobtotting ary O ctober 2018 Eukaryotic cell lines Policy information about cell lines Cell line source(s) Human embryonic kidney HEK293 (Cat# CRL-1573), human prostate cancer PC-3 (Cat# CRL-1435), other:Article Title: Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells Article Snippet: The Article Title: Small-molecule targeting hairpin loop of hTERT promoter G-quadruplex induces cancer cell death Article Snippet: Human Prostate cancer LNCaP , ATCC , Cat# Article Title: FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer. Article Snippet: Prostate cancer (PCa) is a leading cause of cancer mortality in the male population commonly treated with androgen deprivation therapy (ADT) and relapsing as aggressive and androgen-independent castration-resistant prostate cancer (CRPC).. In PCa the FGF/FGFR family of growth factors and receptors represents a relevant mediator of cancer growth, tumor-stroma interaction, and a driver of resistance and relapse to ADT.. In the present work, we validate the therapeutic efficacy the FDA-approved FGFR inhibitor pemigatinib, in an integrated platform consisting of human and murine PCa cells, and the transgenic multistage TRAMP model of PCa that recapitulates both androgen-dependent and CRPC settings. Multiple Displacement Amplification:Article Title: Leucine-rich repeat–containing G protein–coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial–mesenchymal transition Article Snippet: .. Cell Culture:Article Title: Leucine-rich repeat–containing G protein–coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial–mesenchymal transition Article Snippet: .. |
